Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

No effect of oral contraceptives on the metabolism of levetiracetam

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. UGT polymorphisms and lamotrigine clearance during pregnancy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pharmacodynamics of remifentanil. Induced intracranial spike activity in mesial temporal lobe epilepsy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Maternal and fetal outcomes associated with vagus nerve stimulation during pregnancy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Dynamics of muscle activation during tonic-clonic seizures

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Transcranial direct current stimulation in refractory continuous spikes and waves during slow sleep: a controlled study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Transcutaneous Vagus Nerve Stimulation in Patients With Severe Traumatic Brain Injury: A Feasibility Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Why are antiepileptic drugs continued after successful epilepsy surgery in adults?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Psychogenic nonepileptic seizures treated with psychotherapy: Long-term outcome on seizures and healthcare utilization

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Declining malformation rates with changed antiepileptic drug prescribing: An observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
The effect on clearance of levetiracetam (LEV) was estimated in women with epilepsy of childbearing potential using oral contraceptives (OCs). The estimated clearance (plasma concentration/daily dose) was 39 nmol/L/mg (range 14-88 nmol/L/mg) among women who did not use OC (n=30) and 38 nmol/L/mg (range 18-103 nmol/L/mg) among OC users (n=23) (p=0.8). In conclusion, combing LEV and OCs seems safe from a pharmacokinetic perspective.
OriginalsprogEngelsk
TidsskriftEpilepsy Research
Vol/bind95
Udgave nummer3
Sider (fra-til)277-9
Antal sider3
ISSN0920-1211
DOI
StatusUdgivet - 2011

ID: 33245427